Ruxolitinib in corticosteroid refractory graft versus host disease: experience in our center

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY(2021)

Cited 0|Views4
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined